Dissemin is shutting down on January 1st, 2025

Published in

Journal of Health Policy & Outcomes Research, 1, p. 4-11, 2014

DOI: 10.7365/jhpor.2014.5.1

Links

Tools

Export citation

Search in Google Scholar

Current issues of therapy with monoclonal antibodies

Journal article published in 2014 by Karina Jahnz-Różyk ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

The paper presents the most important aspects of treatment with monoclonal antibodies (MABs). Clinical and economic consequences of MABs biosimilars were shown. Access to MABs treatment in drug programs in Poland has been also presented.